Ignite Creation Date:
2025-12-25 @ 12:38 AM
Ignite Modification Date:
2026-03-26 @ 10:15 PM
Study NCT ID:
NCT04931667
Status:
TERMINATED
Last Update Posted:
2022-01-10
First Post:
2021-06-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
3-year, Open-Label Study Evaluating Safety, Tolerability, and Efficacy of Lorecivivint in Subjects With Osteoarthritis of the Knee
Sponsor:
Biosplice Therapeutics, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Osteoarthritis of the Knee | View |